bioAffinity Technologies (BIAF) Notes Payables (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Notes Payables of $61141.0 for Q1 2026, down 41.64% year-over-year from $104766.0 in Q1 2025, and down 41.86% quarter-over-quarter from $105161.0 in Q4 2025.
bioAffinity Technologies (BIAF) Notes Payables (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has reported Notes Payables for 5 consecutive years, with $61141.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables fell 41.64% year-over-year to $61141.0; the TTM figure through Mar 2026 stood at $61141.0 (down 41.64% YoY), while the FY2025 annual figure was $105161.0, down 38.74% from the prior year.
- Notes Payables eased to $61141.0 in Q1 2026 per BIAF's latest filing, from $105161.0 in the prior quarter.
- Across five years, Notes Payables topped out at $325000.0 in Q3 2022 and bottomed at $4106.0 in Q2 2024.
- Historically, Notes Payables has averaged $121295.2 across 4 years, with a median of $104963.5 in 2025.
- Annual changes were most pronounced in 2022 — Notes Payables plunged 63.89% — and 2025, when it jumped 2135.72%.
- bioAffinity Technologies' Notes Payables stood at $325000.0 in 2022, then sank by 47.18% to $171669.0 in 2024, then plunged by 38.74% to $105161.0 in 2025, then tumbled by 41.86% to $61141.0 in 2026.
- Business Quant data shows BIAF's Notes Payables at $61141.0 in Q1 2026, $105161.0 in Q4 2025, and $136396.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | bioAffinity Technologies | 2.38 Mn | -721,990.64 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61,141.00 |
| Dec 31, 2025 | 105,161.00 |
| Sep 30, 2025 | 136,396.00 |
| Jun 30, 2025 | 32,946.00 |
| Mar 31, 2025 | 104,766.00 |
| Dec 31, 2024 | 171,669.00 |
| Sep 30, 2024 | 267,081.00 |
| Jun 30, 2024 | 4,106.00 |
| Mar 31, 2024 | 4,686.00 |
| Sep 30, 2022 | 325,000.00 |
| Dec 31, 2021 | 11.15 Mn |
| Sep 30, 2021 | 900,000.00 |